ADHD medications offer promise in managing menopausal brain fog
An estimated 44% to 60% of perimenopausal women report cognitive changes like forgetfulness and trouble concentrating—also known as brain fog. Despite the effect of these symptoms on quality of life and productivity, there is currently no FDA-approved pharmacological intervention.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.